S&P 500   2,999.61 (+0.06%)
DOW   27,004.13 (-0.08%)
QQQ   193.65 (+0.12%)
AAPL   235.67 (+0.57%)
FB   190.50 (+0.44%)
MSFT   139.72 (+0.18%)
GOOGL   1,253.60 (-0.02%)
AMZN   1,786.83 (-0.20%)
CGC   20.46 (+0.74%)
MU   44.43 (-2.22%)
BABA   174.94 (-0.74%)
GE   9.01 (-0.66%)
TSLA   260.70 (-0.66%)
AMD   31.22 (+0.64%)
T   38.01 (+0.61%)
F   9.17 (+0.88%)
ACB   3.83 (+0.79%)
PRI   124.23 (+0.22%)
NFLX   286.70 (-2.27%)
BAC   30.26 (+0.63%)
GILD   64.98 (-0.28%)
DIS   132.97 (+0.08%)
S&P 500   2,999.61 (+0.06%)
DOW   27,004.13 (-0.08%)
QQQ   193.65 (+0.12%)
AAPL   235.67 (+0.57%)
FB   190.50 (+0.44%)
MSFT   139.72 (+0.18%)
GOOGL   1,253.60 (-0.02%)
AMZN   1,786.83 (-0.20%)
CGC   20.46 (+0.74%)
MU   44.43 (-2.22%)
BABA   174.94 (-0.74%)
GE   9.01 (-0.66%)
TSLA   260.70 (-0.66%)
AMD   31.22 (+0.64%)
T   38.01 (+0.61%)
F   9.17 (+0.88%)
ACB   3.83 (+0.79%)
PRI   124.23 (+0.22%)
NFLX   286.70 (-2.27%)
BAC   30.26 (+0.63%)
GILD   64.98 (-0.28%)
DIS   132.97 (+0.08%)
Log in

Supernus Pharmaceuticals News Headlines (NASDAQ:SUPN)

$26.34
-0.26 (-0.98 %)
(As of 10/18/2019 09:58 AM ET)
Today's Range
$26.16
Now: $26.34
$26.62
50-Day Range
$25.32
MA: $27.31
$29.52
52-Week Range
$24.77
Now: $26.34
$49.47
Volume25,032 shs
Average Volume546,375 shs
Market Capitalization$1.38 billion
P/E Ratio12.85
Dividend YieldN/A
Beta1.61

Headlines

Supernus Pharmaceuticals (NASDAQ SUPN) News Headlines

Source:
DateHeadline
Supernus Pharmaceuticals: Solid Bet Into Year EndSupernus Pharmaceuticals: Solid Bet Into Year End
seekingalpha.com - October 16 at 8:28 PM
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Short Interest Down 9.7% in SeptemberSupernus Pharmaceuticals Inc (NASDAQ:SUPN) Short Interest Down 9.7% in September
www.americanbankingnews.com - October 15 at 7:20 PM
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Insiders Increased Their HoldingsSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Insiders Increased Their Holdings
finance.yahoo.com - October 2 at 4:03 PM
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Expected to Post Earnings of $0.51 Per ShareSupernus Pharmaceuticals Inc (NASDAQ:SUPN) Expected to Post Earnings of $0.51 Per Share
www.americanbankingnews.com - September 30 at 11:25 PM
Traders Purchase High Volume of Supernus Pharmaceuticals Put Options (NASDAQ:SUPN)Traders Purchase High Volume of Supernus Pharmaceuticals Put Options (NASDAQ:SUPN)
www.americanbankingnews.com - September 26 at 7:58 AM
Supernus to Present at the 2019 Cantor Global Healthcare ConferenceSupernus to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 3:29 PM
How Does Investing In Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Impact The Volatility Of Your Portfolio?How Does Investing In Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Impact The Volatility Of Your Portfolio?
finance.yahoo.com - September 2 at 11:36 AM
Supernus Pharmaceuticals Inc (SUPN) President, CEO Jack A. Khattar Bought $190,008 of SharesSupernus Pharmaceuticals Inc (SUPN) President, CEO Jack A. Khattar Bought $190,008 of Shares
finance.yahoo.com - August 27 at 8:10 PM
Supernus to Present at Two September Healthcare ConferencesSupernus to Present at Two September Healthcare Conferences
www.nasdaq.com - August 26 at 7:45 PM
Supernus to Present at Two September Healthcare ConferencesSupernus to Present at Two September Healthcare Conferences
finance.yahoo.com - August 26 at 7:45 PM
Supernus Pharmaceuticals: Anti-CGRPs Are Causing Migraines For This Biotech But Investors Are Too Pessimistic Creating A Compelling OpportunitySupernus Pharmaceuticals: Anti-CGRPs Are Causing Migraines For This Biotech But Investors Are Too Pessimistic Creating A Compelling Opportunity
seekingalpha.com - August 14 at 8:06 PM
Can Value Investors Pick Supernus Pharmaceuticals (SUPN)?Can Value Investors Pick Supernus Pharmaceuticals (SUPN)?
finance.yahoo.com - August 14 at 8:06 PM
These 4 Measures Indicate That Supernus Pharmaceuticals (NASDAQ:SUPN) Is Using Debt SafelyThese 4 Measures Indicate That Supernus Pharmaceuticals (NASDAQ:SUPN) Is Using Debt Safely
finance.yahoo.com - August 14 at 8:37 AM
Supernus Pharmaceuticals Inc (SUPN) Q2 2019 Earnings Call TranscriptSupernus Pharmaceuticals Inc (SUPN) Q2 2019 Earnings Call Transcript
www.fool.com - August 7 at 11:52 PM
Edited Transcript of SUPN earnings conference call or presentation 7-Aug-19 1:00pm GMTEdited Transcript of SUPN earnings conference call or presentation 7-Aug-19 1:00pm GMT
finance.yahoo.com - August 7 at 11:10 PM
Supernus Announces Second Quarter 2019 Financial ResultsSupernus Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 6 at 11:52 PM
Supernus Pharmaceuticals (SUPN) Q2 Earnings Top EstimatesSupernus Pharmaceuticals (SUPN) Q2 Earnings Top Estimates
finance.yahoo.com - August 6 at 11:52 PM
Supernus Pharmaceuticals Q2 2019 Earnings PreviewSupernus Pharmaceuticals Q2 2019 Earnings Preview
seekingalpha.com - August 5 at 11:41 PM
Do Supernus Pharmaceuticalss (NASDAQ:SUPN) Earnings Warrant Your Attention?Do Supernus Pharmaceuticals's (NASDAQ:SUPN) Earnings Warrant Your Attention?
finance.yahoo.com - July 24 at 8:46 AM
Supernus to Host Second Quarter 2019 Earnings Conference CallSupernus to Host Second Quarter 2019 Earnings Conference Call
finance.yahoo.com - July 24 at 8:46 AM
Do Supernus Pharmaceuticals's (NASDAQ:SUPN) Earnings Warrant Your Attention?Do Supernus Pharmaceuticals's (NASDAQ:SUPN) Earnings Warrant Your Attention?
finance.yahoo.com - July 24 at 8:46 AM
How Do Analysts See Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Performing Over The Next Year?How Do Analysts See Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Performing Over The Next Year?
finance.yahoo.com - June 17 at 8:05 PM
Read This Before You Buy Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Because Of Its P/E RatioRead This Before You Buy Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Because Of Its P/E Ratio
finance.yahoo.com - May 30 at 6:43 PM
Supernus to Present at the Jefferies 2019 Global Healthcare ConferenceSupernus to Present at the Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 29 at 6:58 PM
Edited Transcript of SUPN earnings conference call or presentation 8-May-19 1:00pm GMTEdited Transcript of SUPN earnings conference call or presentation 8-May-19 1:00pm GMT
finance.yahoo.com - May 9 at 8:21 AM
Supernus Pharmaceuticals Inc (SUPN) Q1 2019 Earnings Call TranscriptSupernus Pharmaceuticals Inc (SUPN) Q1 2019 Earnings Call Transcript
www.fool.com - May 8 at 1:48 PM
Supernus Pharmaceuticals (SUPN) Lags Q1 Earnings and Revenue EstimatesSupernus Pharmaceuticals (SUPN) Lags Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 8 at 8:22 AM
Supernus Pharmaceuticals misses by $0.13, misses on revenueSupernus Pharmaceuticals misses by $0.13, misses on revenue
seekingalpha.com - May 7 at 7:01 PM
Supernus Announces First Quarter 2019 Financial ResultsSupernus Announces First Quarter 2019 Financial Results
www.globenewswire.com - May 7 at 7:01 PM
Supernus Pharmaceuticals Q1 Earnings PreviewSupernus Pharmaceuticals Q1 Earnings Preview
seekingalpha.com - May 6 at 7:40 PM
Are Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Interest Costs Too High?Are Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Interest Costs Too High?
finance.yahoo.com - May 5 at 5:45 PM
Here’s What Hedge Funds Think About Supernus Pharmaceuticals Inc (SUPN)Here’s What Hedge Funds Think About Supernus Pharmaceuticals Inc (SUPN)
finance.yahoo.com - May 1 at 7:29 PM
Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 30 at 6:53 PM
Supernus to Host First Quarter 2019 Earnings Conference CallSupernus to Host First Quarter 2019 Earnings Conference Call
finance.yahoo.com - April 24 at 6:37 PM
A Note On Supernus Pharmaceuticals, Inc.s (NASDAQ:SUPN) ROE and Debt To EquityA Note On Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) ROE and Debt To Equity
finance.yahoo.com - April 18 at 7:41 PM
A Note On Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) ROE and Debt To EquityA Note On Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) ROE and Debt To Equity
finance.yahoo.com - April 18 at 8:20 AM
Supernus ADHD Candidate Positive in 4th Phase III StudySupernus' ADHD Candidate Positive in 4th Phase III Study
finance.yahoo.com - April 1 at 7:58 PM
Shareholders Are Thrilled That The Supernus Pharmaceuticals (NASDAQ:SUPN) Share Price Increased 296%Shareholders Are Thrilled That The Supernus Pharmaceuticals (NASDAQ:SUPN) Share Price Increased 296%
finance.yahoo.com - April 1 at 7:58 PM
Supernus Pharma Needs Your Attention... Supernus Pharma Needs Your Attention...
www.rttnews.com - March 29 at 4:11 AM
Supernus Pharmas SPN-812 shows mixed results in late-stage ADHD studySupernus Pharma's SPN-812 shows mixed results in late-stage ADHD study
seekingalpha.com - March 28 at 7:27 PM
Supernus reports mixed ADHD drug trial results. So why isnt it worried?Supernus reports mixed ADHD drug trial results. So why isn't it worried?
www.bizjournals.com - March 28 at 7:27 PM
Supernus reports mixed ADHD drug trial results. So why isn't it worried?Supernus reports mixed ADHD drug trial results. So why isn't it worried?
finance.yahoo.com - March 28 at 7:27 PM
Supernus Announces P304 Phase III Data Confirming Positive Results from Previous Three Phase III Studies on SPN-812 in ADHDSupernus Announces P304 Phase III Data Confirming Positive Results from Previous Three Phase III Studies on SPN-812 in ADHD
finance.yahoo.com - March 28 at 8:28 AM
Supernus Hosts Conference Call to Present Topline Results of Final Phase III Study for SPN-812 in Adolescents with ADHDSupernus Hosts Conference Call to Present Topline Results of Final Phase III Study for SPN-812 in Adolescents with ADHD
finance.yahoo.com - March 27 at 7:49 PM
Supernus Pharmaceuticals Does Not Impress In ADHD - Seeking AlphaSupernus Pharmaceuticals Does Not Impress In ADHD - Seeking Alpha
seekingalpha.com - March 19 at 7:46 PM
Aequus Pharmaceuticals: Approaching Breakeven In 2019 And Ongoing Growth In 2020/2021Aequus Pharmaceuticals: Approaching Breakeven In 2019 And Ongoing Growth In 2020/2021
seekingalpha.com - March 15 at 8:30 AM
What Investors Should Know About Supernus Pharmaceuticals, Inc.’s (NASDAQ:SUPN) Financial StrengthWhat Investors Should Know About Supernus Pharmaceuticals, Inc.’s (NASDAQ:SUPN) Financial Strength
finance.yahoo.com - March 14 at 7:21 PM
Supernus Pharmaceuticals IncSupernus Pharmaceuticals Inc
www.bloomberg.com - March 12 at 10:49 PM
Recent Analysis Shows Golar LNG, AG Mortgage Investment Trust, AmerisourceBergen, Caesarstone, Dycom Industries, and Supernus Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of GrowthRecent Analysis Shows Golar LNG, AG Mortgage Investment Trust, AmerisourceBergen, Caesarstone, Dycom Industries, and Supernus Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth
finance.yahoo.com - March 7 at 8:32 AM
Supernus to Present at the 2019 Cowen Health Care ConferenceSupernus to Present at the 2019 Cowen Health Care Conference
finance.yahoo.com - March 6 at 7:35 PM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel